Filtros de búsqueda

Lista de obras de

(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.

artículo científico publicado en 2014

A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy

artículo científico publicado en 2019

A gene panel, including LRP12, is frequently hypermethylated in major types of B-cell lymphoma

artículo científico publicado en 2014

A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma

artículo científico publicado en 2016

A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma

artículo científico publicado en 2016

A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation

artículo científico publicado en 2004

A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphoma

artículo científico publicado en 2013

Activation of coagulation and deep vein thrombosis after bone marrow harvesting and insertion of a Hickman-catheter in ABMT patients with malignant lymphoma

artículo científico publicado en 1996

Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells

artículo científico publicado en 1987

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.

artículo científico publicado en 2017

Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged using immunomagnetic beads

artículo científico publicado en 1994

BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study

artículo científico publicado en 2010

Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial.

artículo científico publicado en 2016

Biodistribution and dosimetry results from a phase 1 trial of (177)Lu-lilotomab satetraxetan antibody-radionuclide conjugate therapy

artículo científico publicado en 2017

Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation

artículo científico

Bone-marrow MR imaging before and after autologous marrow transplantation in lymphoma patients without known bone-marrow involvement ⬇️

artículo científico publicado el 1 de septiembre de 1997

Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011-2016

scientific article published on 20 August 2019

CD34(+) cell enrichment depletes atypical CD30(+) cells from PBPC grafts in patients with HD

artículo científico publicado en 2001

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial

artículo científico publicado en 2003

Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation

artículo científico publicado en 2016

Cell cycle-specific expression and nuclear binding of DNA polymerase alpha

artículo científico publicado en 1991

Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model

artículo científico publicado en 2002

Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up

scientific article published on 15 March 2007

Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up

article

ChlVPP is as effective as alternating ChlVPP/ABOD in advanced stage Hodgkin's disease

artículo científico publicado en 1996

Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity

scientific article published on 27 September 2018

Chronic fatigue is prevalent and associated with hormonal dysfunction in long-term non-Hodgkin lymphoma survivors treated with radiotherapy to the head and neck region

artículo científico publicado en 2015

Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times.

artículo científico publicado en 2011

Clinical stage I and II Hodgkin's disease: long-term results of therapy without laparotomy. Experience at one institution

artículo científico publicado en 1996

Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma

artículo científico publicado en 2013

Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients

artículo científico publicado en 2001

Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma

artículo científico publicado en 1998

Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma

article

Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma

artículo científico publicado en 2014

Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway

artículo científico publicado en 2015

Cyclic AMP has the ability to influence multiple events during B cell stimulation

scientific article published on 01 September 1988

Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma

artículo científico publicado en 2017

Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphoma

artículo científico publicado en 2014

Differential chromatin structure-dependent binding of 7-aminoactinomycin D in normal and malignant bone marrow hematopoietic cells ⬇️

artículo científico publicado el 15 de septiembre de 1992

Differential effects of interferon-gamma and low molecular weight BCGF on growth of human B lymphocytes; interferon-gamma prolongs the increased c-MYC mRNA levels after activation

artículo científico publicado en 1991

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

artículo científico publicado en 2005

Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.

artículo científico publicado en 2016

Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma

artículo científico publicado en 2014

Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes

artículo científico publicado en 2019

Do male lymphoma survivors have impaired sexual function?

artículo científico publicado en 2009

Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year?

artículo científico publicado en 1999

Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

artículo científico

Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols

artículo científico publicado en 2010

Downregulation of c-myc RNA is not a prerequisite for reduced cell proliferation, but is associated with G1 arrest in B-lymphoid cell lines

artículo científico publicado en 1987

Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patients.

artículo científico publicado en 2001

Efficacy of the Nordic and the MSKCC chemotherapy protocols on the overall and progression-free survival in intracranial PCNSL

scientific article published on 30 August 2018

Enhancement characteristics of lymphomatous lymph nodes of the mediastinum.

artículo científico publicado en 2011

Enhancement characteristics of lymphomatous lymph nodes of the neck

artículo científico publicado en 2010

Enhancement characteristics of retroperitoneal lymphomatous lymph nodes

artículo científico publicado en 2013

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

artículo científico publicado en 2011

Entourage: the immune microenvironment following follicular lymphoma.

artículo científico publicado en 2012

Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma.

artículo científico publicado en 2018

Expression of CD18 (integrin beta 2 chain) correlates with prognosis in malignant B cell lymphomas

artículo científico publicado en 1993

FEC mobilized stem cells for high-dose therapy in breast cancer patients. SB6 9401 Study Group

artículo científico publicado en 1999

Fat replacement of Hodgkin disease of bone marrow after chemotherapy: report of three cases

artículo científico publicado en 1996

Fatigue in long-term Hodgkin's Disease survivors: a follow-up study

artículo científico publicado en 2005

Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism

artículo científico publicado en 2014

Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL.

artículo científico publicado en 2010

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

artículo científico publicado en 2020

Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation

scientific article published on 01 January 1990

G-banding and molecular cytogenetic analyses of marginal zone lymphoma

artículo científico publicado en 2005

Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas

artículo científico publicado en 2006

Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones.

artículo científico publicado en 2010

Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy

artículo científico publicado en 2009

Heart Failure and Asymptomatic Left Ventricular Systolic Dysfunction in Lymphoma Survivors Treated With Autologous Stem-Cell Transplantation: A National Cross-Sectional Study.

artículo científico publicado en 2015

High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study

artículo científico publicado en 2011

High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era

artículo científico publicado en 2014

High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy

artículo científico publicado en 2012

High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Bl

artículo científico publicado en 2001

High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells

artículo científico publicado en 2001

High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma

scientific article published on 01 October 1999

High-dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008.

artículo científico publicado en 2013

High-dose therapy with autologous stem cell support for lymphoma--from experimental to standard treatment

artículo científico publicado en 2013

High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas

artículo científico publicado en 2001

Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy

artículo científico publicado en 2013

Hodgkin's disease in a national and hospital population: trends over 20 years

scientific article published on 01 December 1997

Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region

artículo científico publicado en 2015

Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.

artículo científico publicado en 2001

ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience

artículo científico publicado en 2004

Identification of highly methylated genes across various types of B-cell non-hodgkin lymphoma

artículo científico publicado en 2013

Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma

scientific article published on 20 February 2020

Immunomagnetic purging of lymphoma cells from autografts

artículo científico publicado en 1996

Impaired Right Ventricular Function in Long-Term Lymphoma Survivors

artículo científico publicado en 2016

In vitro and in vivo activation of B-lymphocytes: a flow cytometric study of chromatin structure employing 7-aminoactinomycin D

artículo científico publicado en 1988

Infection after splenectomy for Hodgkin's disease

artículo científico publicado en 1990

Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab

artículo científico publicado en 2013

Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy

artículo científico publicado en 2004

Inhibition of Polyphosphoinositide Breakdown and c-myc Induction Accompanying Inhibition of Human B-Cell Activation by Two Monoclonal Antibodies Against the Leucocyte Common Antigen (CD45) ⬇️

artículo científico publicado el 1 de mayo de 1990

Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens

artículo científico publicado en 1989

Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents?

artículo científico publicado en 2018

Karyotyping of diffuse large B-cell lymphomas: loss of 17p is associated with poor patient outcome

artículo científico publicado en 2013

Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma

artículo científico publicado en 1989

Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in Norway.

artículo científico publicado en 2004

Late medical sequelae after therapy for supradiaphragmatic Hodgkin's disease

artículo científico publicado en 1999

Levels of myc protein, as analyzed by flow cytometry, correlate with cell growth potential in malignant B-cell lymphomas

scientific article published on 01 January 1989

Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes

artículo científico publicado en 2019

Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma

artículo científico publicado en 2005

Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy

artículo científico publicado en 2007

Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: a randomized phase II study from the Nordic Lymphoma Group

artículo científico publicado en 2008

Long-term outcome for patients with early stage marginal zone lymphoma and mantle cell lymphoma

Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 years

artículo científico publicado en 2017

Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time

artículo científico publicado en 2002

Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma

artículo científico publicado en 2001

Low levels of monoclonal small B cells in the bone marrow of patients with diffuse large B-cell lymphoma of activated B-cell type but not of germinal center B-cell type

artículo científico publicado en 2010

M-FISH cytogenetic Analysis of Non-Hodgkin Lymphomas with t(14;18)(q32;q21) and add(1)(p36) as a Secondary Abnormality Shows that the Extra Material Often Comes from Chromosome Arm 17q

artículo científico publicado en 2002

MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma.

artículo científico publicado en 2017

Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients

scientific article published on 04 February 2020

Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens

article

Molecular diagnosis of Burkitt's lymphoma

artículo científico publicado en 2006

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

artículo científico publicado en 2003

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

artículo científico publicado en 2022

Mortality is persistently increased in Hodgkin's lymphoma survivors

artículo científico publicado en 2010

Multimodal treatment with ALL-like chemotherapy, Auto-SCT and radiotherapy for lymphoblastic lymphoma

scientific article published on 18 November 2013

Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series

scientific article published on 01 May 2020

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies

artículo científico

No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

artículo científico publicado en 2019

Non-Hodgkin lymphoma with t(14;18): clonal evolution patterns and cytogenetic-pathologic-clinical correlations

scientific article published on 18 January 2007

Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.

artículo científico publicado en 2017

Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma

scientific article published on 01 July 2000

Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens

artículo científico publicado en 2009

Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma

artículo científico publicado en 2020

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

scientific article published on 01 May 2020

Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation

artículo científico publicado en 2016

Penicillin and aminoglycoside in febrile neutropenia

artículo científico publicado en 2008

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project

artículo científico publicado en 2011

Persistent changes in the immune system 4-10 years after ABMT.

artículo científico publicado en 1999

Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

scientific article published on 01 September 2020

Physical activity in Hodgkin's lymphoma survivors with and without chronic fatigue compared with the general population - a cross-sectional study

artículo científico publicado en 2007

Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study

artículo científico publicado en 2016

Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen.

artículo científico publicado en 2007

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

artículo científico publicado en 2007

Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma

artículo científico publicado en 2012

Post-treatment parenthood in Hodgkin's lymphoma survivors

artículo científico publicado en 2007

Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients

artículo científico publicado en 2018

Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma

article

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

article

Primary diffuse large B-cell lymphoma associated with clonally-related monoclonal B lymphocytosis indicates a common precursor cell

artículo científico publicado en 2015

Primary non-Hodgkin's lymphoma of the brain

artículo científico publicado en 1998

Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis

artículo científico publicado en 2000

Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial

artículo científico publicado en 2014

Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation markers

artículo científico publicado en 1999

Prognostic variables and results of salvage treatment in Hodgkin's disease

artículo científico publicado en 1996

Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas

artículo científico publicado en 1998

Purging of tumor cells from leukapheresis products: experimental and clinical aspects

artículo científico publicado en 1996

Quality of life after total or partial gastrectomy for primary gastric lymphoma

artículo científico publicado en 2006

Quality of life in long-term Hodgkin's disease survivors with chronic fatigue.

artículo científico publicado en 2005

Quenching of Hoechst 33258 fluorescence in erythroid precursors

artículo científico publicado en 1990

Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years

artículo científico publicado en 2015

Red Marrow-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with 177Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody-Radionuclide Conjugate

artículo científico publicado en 2016

Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation

artículo científico publicado en 2009

Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study

scientific article published on 06 February 2019

Reply to M. Sorigue et al

artículo científico publicado en 2019

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

scientific article published on 04 July 2018

Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial

artículo científico publicado en 2006

Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study ⬇️

artículo científico publicado en 2010

Sample-Index Misassignment Impacts Tumor Exome Sequencing

Sample-Index Misassignment Impacts Tumour Exome Sequencing.

artículo científico publicado en 2018

Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma

artículo científico publicado en 2014

Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress

artículo científico publicado en 2020

Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation

artículo científico publicado en 2019

Should alternative therapists treat cancer--what is the opinion of oncology health personnel?

artículo científico publicado el 6 de noviembre de 2003

Simultaneous assessment of chromatin structure, DNA content, and antigen expression by dual wavelength excitation flow cytometry ⬇️

artículo científico publicado el 1 de enero de 1991

Socio-medical situation for long-term survivors of Hodgkin's disease: a survey of 459 patients treated at one institution

artículo científico publicado en 1998

Stage I high-grade non-Hodgkin's lymphoma

artículo científico publicado en 2000

Standard CHOP-21 as first line therapy for elderly patients with Hodgkin's lymphoma

scientific article published on 01 March 2007

Stromal gene signatures in large-B-cell lymphomas

artículo científico publicado en 2008

Systemic pneumococcal disease after staging splenectomy for Hodgkin's disease 1969-1980 without pneumococcal vaccine protection: a follow-up study 1994

scientific article published on 01 February 1997

T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab.

artículo científico publicado en 2011

T-cell receptor tau delta +/CD3+4-8-T- cell acute lymphoblastic leukemias: a distinct subgroup of leukemias in children. A report of five cases

TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma

scientific article published on 18 January 2019

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.

artículo científico publicado en 2000

The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy

scientific article published on 06 August 2018

The Norwegian experience with penicillin G plus an aminoglycoside as initial empiric therapy in febrile neutropenia; a review

artículo científico publicado en 2011

The activation-associated antigen 4F2 predicts patient survival in low-grade B-cell lymphomas.

artículo científico publicado en 1987

The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily.

artículo científico publicado en 2011

The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project.

artículo científico publicado en 2012

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

article

The role of surgery in intracranial PCNSL.

artículo científico publicado en 2018

The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy

artículo científico publicado en 2020

The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.

artículo científico publicado en 2016

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2018

Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion

artículo científico publicado en 2019

Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial.

artículo científico publicado en 2007

Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes.

artículo científico publicado en 1987

Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens

artículo científico publicado en 2004

Treatment with growth factors and cytokines in hematologic diseases

artículo científico publicado en 1996

Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma

artículo científico publicado en 2006

Triggering of neoplastic B cellsvia surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets

article

Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan

artículo científico publicado en 2016

Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas

artículo científico publicado en 1998

Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas

artículo científico

Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis.

artículo científico publicado en 2011

Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation

scientific article published on 23 April 2012

Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in Norway

artículo científico publicado en 2004

Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network

article

Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation: A National Cross-Sectional Study

artículo científico publicado en 2016

Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study

artículo científico publicado en 2009

Vitamin D deficiency in patients operated on for gastric lymphoma

artículo científico publicado en 2006

Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma

artículo científico publicado en 2013

[High dose therapy with autologous stem cell support in malignant disorders. Excerpt from the statement by the advisory group of the State Health Services]

scientific article published on 01 September 1996

[High-dose autologous stem cell support in malignant diseases--an established method, uncertain indication]

artículo científico publicado en 1994

[High-dose therapy of cancer with CD34 positive cells as stem cell support]

artículo científico publicado en 1996

[High-dose therapy with autologous stem cell support in malignant lymphoma and breast cancer. Experiences with hematopoietic stem cells isolate from blood]

scientific article published on 01 September 1996

[Intensive chemotherapy in Burkitt's lymphoma and aggressive non-Hodgkin's lymphoma].

artículo científico publicado en 2002

[Molecular diagnosis of malignant lymphomas]

artículo científico publicado en 2009

[Should complementary therapies be offered in hospitals?]

artículo científico publicado en 2004

c-MYC, RB-1, TP53, and centromere 8 and 17 copy number in B-cell non-Hodgkin's lymphomas assessed by dual-color fluorescence in situ hybridization.

artículo científico publicado en 1999

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda